Anterior vs Banjo Health
Two payer side prior authorization platforms split by benefit type. Anterior works medical review, applying clinical AI to the determination with human clinicians approving each recommendation, aimed at plans whose constraint is reviewer capacity. Banjo is pharmacy weighted, reading prescriber notes directly and producing a structured recommendation with the evidence attached rather than a score, with certification at the more demanding risk based tier. A plan running both benefits needs both workflows, since medical necessity and formulary determination are different decisions with different evidence. Neither publishes a bias evaluation, in the one lane where the output can end in care being denied, and the accreditation question transfers real burden to the carrier when the vendor does not hold it.
- It works the medical benefit review for health plans, with clinical AI applied to the determination itself and human clinicians approving each recommendation.
- For a plan whose bottleneck is nurse and physician review capacity, this addresses that queue directly.
- The buyer and workflow are plan side, so the policy library and audit trail are shaped for that regulatory context.
- It is pharmacy benefit weighted and reads prescriber notes directly, producing an inspectable structured recommendation with evidence attached rather than a score.
- Certification is held at the risk based two year tier, which incorporates privacy requirements and is the more demanding assessment.
- For a pharmacy benefit operation the determination workflow differs from medical review, and this is built for it.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Prior authorization is where an AI output most directly delays or denies care, and neither vendor publishes a bias evaluation or subgroup analysis. Washington's rule states that a carrier is not exempt from compliance because it used a third party vendor and requires the programme to meet a national accreditation standard, so vendor accreditation transfers benefit and its absence transfers burden; Anterior holds no such accreditation. Ask both what proportion of AI informed adverse determinations are overturned on appeal, which describes calibration better than any accuracy claim.